Roivant Sciences===Genevant Sciences
Tracked across 3 events · 23 articles · First seen Mar 03, 2026 · Last active Mar 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Roivant Sciences===Genevant Sciences, a subsidiary of Roivant Sciences, is a key beneficiary of the $2.25 billion settlement with Moderna. This settlement resolves all patent infringement litigation related to Moderna's use of Roivant Sciences===Genevant Sciences' LNP delivery technology in its COVID-19 vaccines. Roivant Sciences===Genevant Sciences will grant Moderna a global non-exclusive license for infectious disease applications.
Mar 03, 2026 · 8 articles
Business
Roivant Sciences===Genevant Sciences, a subsidiary of Roivant Sciences, will receive a significant payment from Moderna as part of the settlement, resolving their patent infringement claims over LNP technology. This provides a substantial financial gain for the company.
Mar 03, 2026 · 8 articles
Business
Genevant, a subsidiary of Roivant Sciences, is a recipient of the settlement payment from Moderna, which could be up to $2.25 billion. This resolves legal actions regarding its lipid nanoparticle technology.
Mar 04, 2026 · 7 articles
Roivant Sciences
subsidiary
↔
Roivant Sciences===Genevant Sciences
Roivant Sciences===Genevant Sciences is a subsidiary of Roivant Sciences.
NEWSDESK
Track Roivant Sciences===Genevant Sciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard